Smarter Cancer Care
In collaboration with thousands of physicians around the world, over one million patients improved their outcomes with the Oncotype IQ portfolio of genomic tests.

SABCS 2020 Virtual Symposium

December 8-12, 2020

Join us for a variety of engaging speakers and presentations, including our Industry Product Theater: "Yes or No? Answering chemotherapy and endocrine therapy questions through a case-based discussion with the Oncotype DX® test".

Molecular Profiling in Lung Cancer Webinar

Available On-Demand

View our webinar: Optimizing Molecular Profiling in Non-Small Cell Lung Cancer, explore recent advances in molecular testing, emerging NSCLC biomarkers of disease, and real-world case studies in clinical practice.

New Genomic Test

Oncotype MAP Pan-Cancer Tissue Test

A rapid, comprehensive genomic profiling panel to aid therapy selection for a breadth of solid tumor types.

Western Section of the AUA

Available On-Demand

Join speaker Dr. Rob Reiter for the virtual WAUA symposium on "Commercial Genomic Assays for Localized Prostate Cancer: How Do They Compare?"

UroCareLive Webinar

Available On-Demand

Join the live LUGPA Virtual Crossfire Series discussion "Commercial Genomic Assays for Localized Prostate Cancer: How Do They Compare?" featuring Drs. Neal Shore and Andrew Stephenson.

ASCO20 Virtual Scientific Program

Exact Sciences Showcases Continued Progress in Cancer Diagnostics

See new data for the Oncotype DX Breast Recurrence Score test and how it changes treatment decisions for patients with early-stage breast cancer.
Real People.
Real Results.
When Amy was diagnosed with breast cancer, she was scared. Her Oncotype DX Breast DCIS Score result made her feel in control.
Latest TAILORx Data
The landmark TAILORx results provide definitive answers on which early stage ER+, HER2-, N0 breast cancer patients can benefit from chemotherapy.
Our Response to COVID-19
Oncotype DX tests remain readily available and that our laboratory continues to operate. Our patient-critical work teams continue to operate, following all safety procedures and practices.
Healthcare Savings
How much do ineffective cancer treatments cost the healthcare system? In the US alone, Oncotype IQ tests have saved more than $3.5 billion.
Making cancer care smarter.®

We may use cookies to improve your experience with our website and to provide you with more relevant content based on your interests. To learn more about what information we collect, how we use it, and how to manage cookies, review our Privacy Policy.